IntuitionLabs
Databricks GxP validation and 21 CFR Part 11 compliance for pharmaceutical lakehouse deployments

Databricks GxP Validation & 21 CFR Part 11 Compliance

Risk-based GAMP 5 validation, 21 CFR Part 11 compliance mapping, Unity Catalog configuration baselines, and audit-ready IQ/OQ/PQ for regulated pharma Databricks deployments.

Our Databricks Compliance Services

We deliver complete validation packages for Databricks deployments in regulated pharma and biotech — from initial gap assessment through IQ/OQ/PQ execution to ongoing periodic review.

Assessment
21 CFR Part 11 Gap Analysis
Systematic mapping of Databricks capabilities against every 21 CFR Part 11 requirement. Deliverable includes gap analysis, remediation plan, configuration baseline, and SOP templates.
Request gap assessment
Validation
GAMP 5 IQ/OQ/PQ
Full validation package aligned with ISPE GAMP 5 Second Edition — URS, FRS, risk assessment, traceability matrix, IQ/OQ/PQ protocols, and summary reports. Risk-based rigor proportional to GxP impact.
Learn about CSV
Operations
Ongoing Compliance
Annual periodic review, runtime upgrade validation, change control administration, audit preparation, and SOP maintenance. Keep your validated Databricks deployment compliant as the platform evolves.
View managed services

Risk-Based Validation Aligned with GAMP 5

Our validation approach applies the ISPE GAMP 5 Second Edition risk-based philosophy. Databricks platform components are typically Category 3 (vendor-managed), configured components like Unity Catalog grants and workflows are Category 4, and custom notebooks, ML pipelines, and agents are Category 5. We apply validation rigor proportional to patient risk, data criticality, and GxP impact — focused effort on high-risk components, streamlined documentation for low-risk ones.

Risk-based validation approach for Databricks components aligned with GAMP 5 categorization

Configuration Baseline for Unity Catalog

We define and document a compliance configuration baseline for your Databricks workspace covering Unity Catalog governance (catalog/schema/table RBAC, row filters, column masks), workspace security (SSO, SCIM, network policies, IP access lists, private connectivity), audit logging (system tables retention, delivery destination), and encryption (customer-managed keys, TLS configuration). This baseline is version-controlled in Terraform and enforced by CI/CD — configuration drift triggers alerts and remediation workflows.

Unity Catalog configuration baseline for compliant Databricks workspace in pharmaceutical environments

Audit Trail Design for FDA and EMA

Databricks produces audit evidence through multiple mechanisms: system tables for workspace and account actions, Delta Lake time travel for immutable data history, and MLflow for model lifecycle events. We configure retention, immutability, monitoring, and review procedures that satisfy 21 CFR Part 11, EU Annex 11, and MHRA ALCOA+ expectations.

Audit trail design for Databricks satisfying FDA and EMA regulatory requirements

Our Databricks Validation Deliverables

Validation Plan

Project validation plan defining scope, GAMP 5 categorization, risk assessment approach, roles and responsibilities, deliverables, and acceptance criteria — the master document anchoring all subsequent validation work.

Start your validation

URS, FRS & Design Specs

User Requirements Specification, Functional Requirements Specification, and Design Specifications for the Databricks deployment — with traceability to downstream test protocols and production evidence.

Learn about CSV

Risk Assessment

Risk assessment for each GxP workflow using FMEA or equivalent methodology, aligned with ICH Q9 quality risk management. Risk levels drive validation rigor and ongoing monitoring intensity.

See Part 11 services

IQ/OQ/PQ Protocols

Installation, Operational, and Performance Qualification protocols with automated test execution via Databricks Asset Bundles and pytest — generating reproducible test evidence for auditors.

Discuss IQ/OQ/PQ

Traceability Matrix

Requirements traceability matrix linking every user requirement through functional specs, design, test cases, and production evidence — a single document auditors can use to verify complete coverage.

Request sample

Validation Summary Report

Summary report consolidating validation execution, deviations, remediation, and final release recommendation — signed by the quality unit as formal authorization for production use.

View ongoing support

Today's business insights

Profitable growth in the AI solutions industry

Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.

More insights on unlock profitable growth in ai solutions
Profitable growth in the AI solutions industry

Databricks Controls Mapped to 21 CFR Part 11

🔐

Access Control — §11.10(d)

Unity Catalog RBAC with fine-grained permissions, row filters, and column masks. Workspace SSO via SAML, SCIM provisioning, MFA enforcement, IP allowlists, and private connectivity.

📋

Audit Trail — §11.10(e)

System tables for audit logs capturing every workspace and Unity Catalog action, Delta Lake time travel for data history, MLflow for model lifecycle — all with configurable retention and alerting.

✅

Validation — §11.10(a)

GAMP 5 risk-based validation with URS, FRS, design specs, IQ/OQ/PQ protocols, traceability matrix, and validation summary report signed by the quality unit.

✍️

Electronic Signatures — §11.50–11.300

SAML-based signatures with MFA, Git-signed commits for notebook approvals, MLflow model stage transitions with quality unit approval. Meets non-repudiation and unique identity requirements.

💾

Record Retention — §11.10(c)

Delta Lake VACUUM retention policies, system table retention configuration, Vault protection for critical records, and disaster recovery across cloud regions with documented RPO/RTO.

📚

Training & Documentation — §11.10(i)/(k)

Role-based training matrix, documented SOPs integrated with your QMS, controlled documentation for every Databricks configuration, and training records linked to access grants.

Data Integrity and ALCOA+ on Databricks

Data integrity is the bedrock of regulatory compliance. We implement Databricks controls mapped to MHRA ALCOA+ principles: Attributable (Unity Catalog identity tracking), Legible (Delta readable formats), Contemporaneous (system-generated timestamps), Original (immutable Delta versions), Accurate (data quality expectations in DLT), Complete (reconciliation checks), Consistent (schema enforcement), Enduring (retention and backup), Available (HA and DR). Each principle is mapped to specific Databricks features and validation evidence.

Data integrity and ALCOA+ principles implemented on Databricks for regulated pharmaceutical data

AI/ML Model Validation for GxP Use

AI/ML validation extends traditional CSV. We follow FDA Good Machine Learning Practice principles and the FDA AI/ML draft guidance. Every model has MLflow-tracked lineage, predetermined change control plans, Lakehouse Monitoring for drift, Agent Evaluation for LLM quality, and human-in-the-loop gates for GxP decisions.

AI and ML model validation for GxP use cases on Databricks Mosaic AI platform

Disaster Recovery and Business Continuity

Pharma regulations require documented backup, recovery, and business continuity procedures. Databricks supports multi-region deployments, cross-region Delta replication, Unity Catalog metastore backup, and workspace-level disaster recovery. We implement DR procedures with documented RPO/RTO targets, run periodic recovery drills with documented evidence, and integrate DR testing into the ongoing validation lifecycle satisfying EU Annex 11 business continuity requirements.

Disaster recovery and business continuity architecture for validated Databricks pharmaceutical deployments

Our Validation Delivery Model

IntuitionLabs delivers Databricks validation using a proven four-phase model aligned with GAMP 5 Second Edition. We balance regulatory rigor with agile delivery, using infrastructure-as-code and automated testing to produce reproducible evidence while avoiding documentation bloat.

Gap Assessment

Part 11 gap analysis, GAMP 5 categorization, risk assessment, and validation plan — typically 2 to 3 weeks.

Specification & Testing

URS, FRS, design specs, IQ/OQ/PQ protocols, automated test execution, traceability matrix — 6 to 12 weeks.

Release & Periodic Review

Validation summary, quality unit approval, go-live, and ongoing periodic review with runtime upgrade support.

Frequently Asked Questions

No cloud platform is "GxP-compliant out of the box" — compliance is a property of how the system is configured, validated, and operated, not a vendor checkbox. Databricks provides the technical primitives required for GxP (Unity Catalog access control, audit logs, encryption, SSO, Delta Lake time travel) and publishes a GxP readiness overview, but you still need a complete validation package: URS, FRS, risk assessment, IQ/OQ/PQ protocols, SOPs, and periodic review. IntuitionLabs delivers this validation package and leaves you with a defensible compliance posture that passes FDA and EMA audits.
Our Part 11 gap assessment systematically maps Databricks capabilities against every requirement in 21 CFR Part 11 Subparts B (electronic records) and C (electronic signatures). We evaluate access controls (Unity Catalog RBAC, network policies, IP allowlists), audit trails (system tables, Delta Lake time travel, MLflow tracking), electronic signatures (SAML/SCIM, MFA, signed commits), record retention (Delta retention, Vault protection), and operational procedures (change control, training, periodic review). The deliverable is a documented gap analysis with remediation plan, configuration baseline, and SOP templates.
ISPE GAMP 5 (Second Edition) classifies software into categories that drive the validation effort. The Databricks platform itself is typically Category 3 (non-configured commercial product) for vendor-managed services, while configured components — Unity Catalog grants, workflows, notebooks, ML pipelines, agents — are Category 4 (configured) or Category 5 (custom-developed). Our validation strategy applies risk-based rigor: Category 3 components get vendor audit reports and platform configuration verification, Category 4/5 components get full specification, design, and testing documentation proportional to patient risk, data criticality, and GxP impact.
Databricks generates comprehensive audit logs via system tables for audit logs capturing every workspace, account, and Unity Catalog action with user identity, timestamp, action type, and object affected. Delta Lake adds transactional history via time travel showing every change to every table with the user and operation responsible. MLflow tracks every model lifecycle event. Combined, these satisfy the Part 11 requirement for secure, computer-generated, time-stamped audit trails. We configure retention policies, immutability controls, and alerting that meet FDA expectations for audit trail review per FDA data integrity guidance.
Pipelines and notebooks are configured or custom code (GAMP 5 Category 4 or 5) and require specification, design, testing, and change control proportional to risk. Our approach implements infrastructure-as-code using Databricks Asset Bundles, version-controlled notebooks in Git, automated test suites (unit, integration, data quality), and CI/CD pipelines that enforce quality gates. Each release is tied to a change request, requirements traceability matrix, and test evidence — giving auditors a clear chain from user requirements to production deployment. For Delta Live Tables, we add expectations (data quality rules) that fail the pipeline on integrity violations.
A complete Databricks validation package includes SOPs for user management (onboarding, periodic access review, offboarding), change control (CAB process, impact assessment, risk classification), backup and recovery (Delta retention, workspace backup, disaster recovery), security incident response, audit trail review, periodic review (typically annual), vendor management (Databricks platform changes, runtime upgrades), and system administration. We deliver customizable SOP templates aligned with your existing quality management system and ICH Q10, not generic documents — they integrate with your TrackWise, MasterControl, or Veeva QMS.
Databricks Runtime upgrades are a recurring change event (new versions released frequently, with support windows typically 12 to 24 months). We implement a risk-based upgrade process: review release notes for impacts to validated workflows, test in a qualified staging workspace with regression test suites, document deviations and remediation, obtain quality unit approval, and promote to production via Asset Bundles. For Long-Term Support (LTS) releases, we typically align major upgrades to annual periodic review cycles. This keeps the platform current with security patches while maintaining the documentation rigor auditors expect.
Yes, with proper controls. ICH E6(R3) GCP expects computerized systems handling clinical data to have documented validation, controlled access, audit trails, data integrity controls, and disaster recovery. Databricks can satisfy all of these when properly configured. For clinical trial lakehouses, we implement study-level access using Unity Catalog row filters and column masks, integrate CDISC standards (SDTM, ADaM) in Delta Live Tables, establish immutable audit trails via time travel and system tables, and document the full validation lifecycle. The result is a clinical data platform that passes ICH E6(R3) and Part 11 Scope and Application scrutiny.
AI/ML validation requires extensions to traditional CSV. We follow FDA Good Machine Learning Practice guiding principles and the recent FDA AI/ML draft guidance. Each model is packaged in MLflow with training data lineage, parameters, evaluation metrics, and approval history. We implement predetermined change control plans for model updates, production monitoring for drift detection via Lakehouse Monitoring, and human-in-the-loop gates for GxP decisions. Agent Evaluation scores models against SME-labeled golden datasets with coverage for factual accuracy, safety, and bias — all stored as audit artifacts.
Validation scope and cost vary widely based on risk classification, data types, and existing QMS maturity. A focused validation of a single GxP workflow (e.g., a clinical enrollment forecasting pipeline) typically runs 6 to 10 weeks with a 2 to 3 person consulting team. A full workspace validation for a new pharma Databricks deployment including 10+ GxP pipelines, ML models, and integration points ranges from 16 to 24 weeks. Ongoing periodic review (typically annual) is usually 2 to 4 weeks of consulting effort plus internal quality unit review. We scope each engagement during discovery with a detailed effort estimate so there are no budget surprises.
EU Annex 11 extends GMP requirements to computerized systems used in European pharma manufacturing and testing. Our validation approach covers all Annex 11 principles including risk management, personnel qualification, suppliers and service providers (Databricks vendor qualification), validation lifecycle, data (accuracy, completeness, retention), electronic signatures, security, and incident management. We also align with MHRA GxP Data Integrity Guidance ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available) — with explicit mapping of Databricks controls to each principle.
Yes. Databricks validation is not a one-time event — it requires ongoing effort to maintain compliance as the platform evolves. Our managed compliance service provides recurring support: periodic review coordination (annual compliance review with updated risk assessment), runtime upgrade validation (risk review, staging testing, documentation), change control administration (CAB facilitation, impact assessment support), audit preparation (FDA, EMA, MHRA inspection readiness), and SOP maintenance. Clients typically engage us on a monthly retainer sized to their validation footprint. See our managed services overview for scoping details.
Ready to Validate Your Databricks Deployment?
Ready to Validate Your Databricks Deployment? image

Ready to Validate Your Databricks Deployment?

Book a validation workshop to assess your current state, scope the gap analysis, and plan your path to GxP compliance. From Part 11 readiness through IQ/OQ/PQ to ongoing periodic review — we deliver audit-ready Databricks validation packages.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting